These services may or may not be covered by your HealthPartners plan. Please see your plan documents for your specific coverage information. If there is a difference between this general information and your plan documents, your plan documents will be used to determine your coverage.
PTNS is generally covered subject to the indications listed below and per your plan documents.
PTNS is covered for the treatment of overactive bladder and associated symptoms of urinary frequency, urge incontinence, and urinary urgency, when all of the following are present:
- Symptoms have been present at least 12 months and have resulted in a significant limitation of activities of daily living.
- Active urinary tract infections and anatomical abnormalities of the lower urinary tract have been excluded as a source of urinary dysfunction.
- Conservative treatment which may include: Behavioral treatments such as biofeedback, fluid management, pelvic floor exercises, timed voids, etc. and/or Pharmacotherapies (at least 2 different anti-cholinergic drugs or a combination of an anti-cholinergic and a tricyclic anti-depressant) have been tried for at least 3 months and have failed.
Continued coverage beyond the initial 12 treatments will be considered on a case by case basis depending on documentation of individual member’s response to the treatment.
PTNS for the treatment of all other indications, including stress incontinence, is not covered.
Percutaneous tibial nerve stimulation (PTNS) is a 30 minute office based treatment for overactive bladder and associated symptoms. A needle electrode is inserted near the tibial nerve, which carries electric impulses from a hand-held stimulator to the sacral plexus. Currently, the Urgent PCTM Neuromodulation System and the NURO system are the only FDA-cleared systems available to provide PTNS treatment.
If available, codes for a procedure, device or diagnosis are listed below for informational purposes only, and do not guarantee member coverage or provider reimbursement. The list may not be all inclusive.
Posterior tibial neurostimulation, percutaneous needle electrode, single treatment, includes programming
CPT Copyright American Medical Association. All rights reserved. CPT is a registered trademark of the American Medical Association.
This information is for most, but not all, HealthPartners plans. Please read your plan documents to see if your plan has limits or will not cover some items. If there is a difference between this general information and your plan documents, your plan documents will be used to determine your coverage. These coverage criteria may not apply to Medicare Products if Medicare requires different coverage. For more information regarding Medicare coverage criteria or for a copy of a Medicare coverage policy, contact Member Services at 952-883-7979 or 1-800-233-9645.
- ECRI Institute. (2012).. Posterior Tibial Nerve Stimulation for Treating Urge Incontinence. Plymouth Meeting, PA. ECRI Institute.
- Hayes, Inc. Hayes Medical Technology Directory Report. Percutaneous Tibial Nerve Stimulation for the Treatment of Lower Urinary Tract Dysfunction. Lansdale, PA: Hayes, Inc. December, 2014. Reviewed November 2016.
- National Institute for health and Care Excellence (NICE) (2010). Percutaneous posterior tibial nerve stimulation for overactive bladder syndrome.
- Lukacz, E.S. Treatment of urinary incontinence in women. In: UpToDate, Brubaker, L. & Schmader K. (Ed), UpToDate, Waltham, MA (Accessed on July 19, 2017).
- Peters, K.M., Carrico, D.J., MacDiarmid, S.A., Wooldridge, L. S., Khan, A.U., McCoy, C.E., Franco, N. & Bennett, J.B. Sustained Therapeutic Effects of Percutaneous Tibial Nerve Stimulation: 24-month Results of the STEP Study. Neurourology and Urodynamics. 2013 Jan;32(1):24-9
- Stewart F, Gameiro OLF, El Dib R, Gameiro MO, Kapoor A, Amaro JL. Electrical stimulation with non-implanted electrodes for overactive bladder in adults. Cochrane Database of Systematic Reviews 2016, Issue 4. Art. No.: CD010098. DOI: 10.1002/14651858.CD010098.pub3.